Pharmaceuticals & Therapeutics

A new report reveals substance use costs Canada's healthcare system $16.4B annually, with alcohol and tobacco driving 90% of the bill. It's not just addiction.

How did a simple string cheese win a top award? Inside the rigorous science and cooperative ethos that made Organic Valley Stringles a Good Housekeeping winner.

As digital fatigue burns out the modern workforce, a surprising counter-trend emerges. We explore why Gen Z is leading a return to analog tools, and how one company’s retro catalog reveals the future of work.

ICL Group's successful $800M notes offering signals strong investor confidence, securing long-term capital to fund its strategic shift into specialty products.

As Colorado's special education needs grow, private schools like The ACES report success. But what does this model reveal about the broader system?

A forgotten corner of oncology is set for a 14.2% CAGR. A new wave of drugs for chemo-induced neuropathy signals a major market realignment.

LiberNovo's new Maxis chair isn't just furniture; it's a challenge to the flawed, one-size-fits-all systems that fail a growing part of the workforce.

Nomic and the Wellcome Sanger Institute unite to profile immune diversity in underrepresented populations, using proteomics to bridge the gap from gene to function.

The U.S. life/annuity industry’s Q1 income fell by double digits, yet net profits jumped 16%. We dissect the financial engineering behind this paradox.

As nations race to finalize a pandemic treaty, a battle over enforceable equity threatens to derail the entire process. Will it be a new era of cooperation or a repeat of past failures?

A new partnership aims to disrupt the opaque PBM industry. By pairing a transparent model with modern tech, it could finally lower your prescription costs.

A Kalamazoo company is betting on advanced chemistry to solve the one flaw holding back the countertop resurfacing industry—a move that could redefine the market.

A Google spin-off is auctioning AI-developed scent molecules, challenging a secretive, century-old industry. This is how technology is digitizing smell.

A new manufacturing patent for pelareorep de-risks Oncolytics' path to market, protecting the drug until 2044 and signaling commercial readiness.

A pilot study shows light therapy improving memory in MCI patients, fueling the at-home neurotech boom. But can Vielight turn scientific promise into market reality?

A new program in Nevada is using breath-based tech to tackle first responder burnout. But can a simple device truly change the complex health of those who serve?

A major survey names Bonafide Health's products #1 in their class. We explore the strategy behind the headlines and what it signals for women's health.

After a fatal crash, a private jet operator is publicly demanding regulators and GE fix a critical safety gap where known corrosion goes unreported.

Kevin's Natural Foods enters the breakfast fray with Scramble Starters, a move that's less about eggs and more about a calculated strategy to disrupt the market.

A small med-tech firm is betting its future on fingerprint sweat. Can its novel drug test pass the FDA's rigorous trials and disrupt a billion-dollar market?